November 23, 2016 - By Adrian Mccoy
Aptargroup Inc’s director Peter Pfeiffer unloaded 30,000 shares of the publicly listed company in sold with a broker dated November 23, 2016. Peter Pfeiffer’s shares were sold at the avg market share price which was $75.2, for a cumulative sell value of $2,257,276. The stocks unloading will most probably not remain unnoticed as it was significant. Presently, he owns a total of 872,402 shares or 1.39% of Aptargroup Inc’s market capitalization.
Out of 6 analysts covering AptarGroup Inc (NYSE:ATR), 2 rate it a “Buy”, 0 “Sell”, while 4 “Hold”. This means 33% are positive. $84 is the highest target while $72 is the lowest. The $77.75 average target is 2.99% above today’s ($75.49) stock price. AptarGroup Inc has been the topic of 12 analyst reports since September 10, 2015 according to StockzIntelligence Inc. The stock has “Neutral” rating given by Robert W. Baird on Tuesday, January 5. The stock of AptarGroup, Inc. (NYSE:ATR) has “Outperform” rating given on Monday, November 16 by Robert W. Baird. The company was maintained on Friday, September 9 by Robert W. Baird. The firm earned “Hold” rating on Monday, October 31 by Vertical Research. The company was initiated on Tuesday, November 10 by Macquarie Research. The firm has “Market Perform” rating given on Thursday, September 10 by BMO Capital Markets. The firm has “Buy” rating given on Monday, November 2 by Deutsche Bank. On Tuesday, September 15 the stock rating was upgraded by Bank of America to “Buy”. The company was initiated on Thursday, October 13 by Jefferies.
Insitutional Activity: The institutional sentiment decreased to 1.05 in 2016 Q2. Its down 0.09, from 1.14 in 2016Q1. The ratio turned negative, as 39 funds sold all AptarGroup, Inc. shares owned while 88 reduced positions. 26 funds bought stakes while 119 increased positions. They now own 53.39 million shares or 1.42% less from 54.16 million shares in 2016Q1.
Victory Cap Management accumulated 0.4% or 1.27M shares. Advisory Ser Networks Limited Liability holds 5,348 shares or 0.1% of its portfolio. Moreover, Ironbridge Capital Mgmt Lp has 0.45% invested in AptarGroup, Inc. (NYSE:ATR) for 129,287 shares. Hightower Ltd Liability owns 5,752 shares or 0.01% of their US portfolio. First Eagle Invest Limited Liability Company holds 0% of its portfolio in AptarGroup, Inc. (NYSE:ATR) for 14,129 shares. Gemmer Asset Management Limited Liability Corp, a California-based fund reported 224 shares. City Holdg accumulated 0% or 63 shares. Guyasuta Investment Advsr has 18,310 shares for 0.19% of their US portfolio. Retirement Sys Of Alabama has 0.08% invested in the company for 172,954 shares. Millennium Management Ltd Liability Com has invested 0% of its portfolio in AptarGroup, Inc. (NYSE:ATR). Fmr Limited Company has invested 0% of its portfolio in AptarGroup, Inc. (NYSE:ATR). Citadel Advisors Limited Liability Corporation has 51,432 shares for 0% of their US portfolio. Oppenheimer & reported 4,558 shares or 0.01% of all its holdings. Johnson Grp Inc accumulated 2,900 shares or 0.03% of the stock. Moody State Bank Tru Division owns 4,392 shares or 0.02% of their US portfolio.
Insider Transactions: Since June 1, 2016, the stock had 0 insider purchases, and 4 selling transactions for $7.12 million net activity. Haffar Salim also sold $3.96 million worth of AptarGroup, Inc. (NYSE:ATR) on Friday, September 2. 3,000 AptarGroup, Inc. (NYSE:ATR) shares with value of $235,760 were sold by Kuhn Robert. $1.00 million worth of AptarGroup, Inc. (NYSE:ATR) was sold by HARRIS KING W. HAGGE STEPHEN J had sold 25,000 shares worth $1.91 million on Wednesday, June 1.
The stock closed at $75.49 during the last session. It is down 3.93% since April 21, 2016 and is downtrending. It has underperformed by 9.26% the S&P500.
AptarGroup, Inc. is a provider of a range of packaging, dispensing and sealing solutions, primarily for the beauty, personal care, home care, prescription drug, consumer healthcare, injectables, food and beverage markets. The company has a market cap of $4.81 billion. The Firm has manufacturing facilities located in North America, Europe, Asia and South America. It has a 24.49 P/E ratio. The Company’s divisions include Beauty + Home, Pharma and Food + Beverage.
According to Zacks Investment Research, “Aptargroup Inc. is a leader in the design, manufacture and sale of three categories of consumer product dispensing systems: pumps, closures and aerosol valves. The company focuses on providing value-added dispensing systems to global consumer product marketers in the personal care, fragrance/cosmetics, pharmaceutical, household/industrial products and food industries. Value-added packaging allows consumers to conveniently dispense a product, in an aesthetically attractive package, which consistently meets required usage or dosage characteristics.”
Analysts await AptarGroup, Inc. (NYSE:ATR) to report earnings on February, 2. They expect $0.66 EPS, down 1.49% or $0.01 from last year’s $0.67 per share. ATR’s profit will be $42.05 million for 28.59 P/E if the $0.66 EPS becomes a reality. After $0.82 actual EPS reported by AptarGroup, Inc. for the previous quarter, Wall Street now forecasts -19.51% negative EPS growth.
Another recent and important AptarGroup, Inc. (NYSE:ATR) news was published by Nasdaq.com which published an article titled: “AptarGroup, Inc. (ATR) Ex-Dividend Date Scheduled for October 31, 2016” on October 28, 2016.
AptarGroup, Inc., incorporated on September 3, 1992, is a well-known provider of a range of packaging, dispensing and sealing solutions, primarily for the beauty, personal care, home care, prescription drug, consumer healthcare, injectables, food and beverage markets. The Firm has manufacturing facilities located in North America, Europe, Asia and South America. The Company’s divisions include Beauty + Home, Pharma and Food + Beverage. It offers various dispensing and sealing solutions. The Company’s primary products are dispensing pumps, closures and aerosol valves. It also makes and sells elastomer primary packaging components, which include stoppers for infusion, antibiotic, lyophilization and diagnostic vials. The Company’s elastomer components also include pre-filled syringe components, such as plungers, needle shields, tip caps and cartridges, as well as dropper bulbs and disposable syringe plungers.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Adrian Mccoy